ALPHA-0602

N/A

Report date: 2022/06/27 10:53:25

Base Information

Drug NameALPHA-0602
Drug Alias NameProgranulinALPHA-0602ND-602Alpha-602
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionProgranulin gene transference
TargetsProgranulin
Therapy Area/IndicationsMuscular Atrophy, SpinalAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlpha Cognition IncNeurodyn
China Registration ClassN/A

Develop Information

Active CompaniesAlpha Cognition Inc
Inactive CompaniesN/A
Active IndicationsMuscular Atrophy, SpinalAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A